Review

Clinical Application of Treating Biofilms-Associated Infections in Family Medicine

Authors: William K. Johnjulio, MD, LaDonna H. Fuge, MD, Swati Srivastava, MD, Christopher Post, MD

Abstract

Abstract: The management of common infections in family medicine may be complicated by poor treatment response or infection recurrence. In many cases, difficulty in treating these infections can be explained by the important role of biofilms, complex microbial communities with unique survival properties that promote infection resistance, recurrence, and persistence. Biofilms have been demonstrated to play important roles in infections involving the sinuses, ears, and ischemic wounds. Biofilms also commonly grow on medical devices, such as indwelling catheters, where they serve as an important nidus of persistent infection. Understanding the role of biofilms in medical infections suggests preventive and treatment strategies that will directly target the important resistive mechanisms of biofilms.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Cherry DK, Hing E, Woodwell DA, et al. National Ambulatory Medical Care Survey: 2006 summary. Natl Health Stat Rep 2008; 3: 1–39.
 
2. Fendrick AM, Saint S, Brook I, et al. Diagnosis and treatment of upper respiratory tract infections in the primary care setting. Clin Ther 2001; 23: 1683–1706.
 
3. Pintucci JP, Corno S, Garotta M. Biofilms and infections of the upper respiratory tract. Eur Rev Med Pharmacol Sci 2010; 14: 683–690.
 
4. Al-Mutairi D, Kitty SJ. Bacterial biofilms and the pathophysiology of chronic rhinosinusitis. Curr Opin Allergy Clin Immunol 2011; 11: 18–23.
 
5. Hall-Stoodley L, Hu FZ, Gieseke A, et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 2006; 296: 202–211.
 
6. Smith A, Buchinsky FJ, Post JC. Eradicating chronic ear, nose and throat infections: a systematically conducted literature review of advances in biofilm treatment. Otolaryngol Head Neck Surg 2011; 144: 338–347.
 
7. Prince AA, Steiger JD, Khalid AN, et al. Prevalence of biofilm-forming bacteria in chronic rhinosinusitis. Am J Rhinol 2008; 22: 239–245.
 
8. Hoa M, Syamal M, Schaeffer MA, et al. Biofilms and chronic otitis media: an initial exploration into the role of biofilms in the pathogenesis of chronic otitis media. Am J Otolaryngol 2010; 31: 241–245.
 
9. Zuliani G, Carlisle M, Duberstein A, et al. Biofilm density in the pediatric nasopharynx: recurrent acute otitis media versus obstructive sleep apnea. Ann Otol Rhinol Laryngol 2009; 118: 519–524.
 
10. Macleod SM, Stickler DJ. Species interactions in mixed-community crystalline biofilms on urinary catheters. J Med Microbiol 2007; 56: 1549–1557.
 
11. James GA, Swogger E, Wolcott R, et al. Biofilms in chronic wounds. Wound Repair Regen 2008; 16: 37–44.
 
12. Meltzer EO, Hamilos DL. Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines. Mayo Clin Proc 2011; 86: 427–443.
 
13. Brem H, Sheehan P, Rosenberg J, et al. Evidence-based protocol for diabetic foot ulcers. Plast Reconstr Surg 2006; 117 (7 suppl): S193–S209.
 
14. Harvey R, Hannan SA, Badia L, et al. Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Database Syst Rev 2007: CD006394.
 
15. Rabago D. The prescribing patterns of Wisconsin family physicians surrounding saline nasal irrigation for upper respiratory conditions. WMJ 2009; 108: 145–150.
 
16. Rabago D, Zgierska A. Saline nasal irrigation for upper respiratory conditions. Am Fam Physician 2009; 80: 1117–1119.
 
17. Nasal irrigation (nasal wash). Available at: www.fammed.wisc.edu/research/past-projects/nasal-irrigation. Accessed February 24, 2011.
 
18. Chiu AG, Palmer JN, Woodworth BA, et al. Baby shampoo nasal irrigations for the symptomatic post-functional endoscopic sinus surgery patient. Am J Rhinol 2008; 22: 34–37.
 
19. Keen M, Foreman A, Wormald PJ. The clinical significance of nasal irrigation bottle contamination. Laryngoscope 2010; 120: 2110–2114.
 
20. Bartley J, Young D. Ultrasound as a treatment for chronic rhinosinusitis. Med Hypotheses 2009; 73: 15–17.
 
21. Young D, Morton R, Bartley J. Therapeutic ultrasound as treatment for chronic rhinosinusitis: preliminary observations. J Laryngol Otol 2010; 124: 495–499.
 
22. Ungkanont K, Damrongsak S. Effect of adenoidectomy in children with complex problems of rhinosinusitis and associated diseases. Int J Pediatr Otorhinolaryngol 2004; 68: 447–451.
 
23. Zuliani G, Carron M, Gurrola J, et al. Identification of adenoid biofilms in chronic rhinosinusitis. Int J Pediatr Otorhinolaryngol 2006; 70: 1613–1617.
 
24. Brietzke SE, Brigger MT. Adenoidectomy outcomes in pediatric rhinosinusitis: a meta-analysis. Int J Pediatr Otorhinolaryngol 2008; 72: 1541–1545.
 
25. Nistico L, Kreft R, Gieseke A, et al. An adenoid reservoir for pathogenic biofilm bacteria. J Clin Microbiol 2011; 49: 1411–1420.
 
26. Rosenfeld RM, Andes D, Bhattacharyya N, et al. Clinical practice guideline: adult sinusitis. Otol Head Neck Surg 2007; 137 (suppl): S1–S31.
 
27. Academy of Pediatrics. Clinical practice guideline: management of sinusitis. Pediatrics 2001; 108: 798–808.
 
28. Suh JD, Cohen NA, Palmer JN. Biofilms in chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2010; 18: 27–31.
 
29. Comsstock RH, Lam K, Mikula S. Topical antibiotic therapy of chronic rhinosinusitis. Curr Infect Dis Rep 2010; 12: 88–95.
 
30. Wallwork B, Coman W, Mackay-Sim A, et al. Controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope 2006; 116: 189–193.
 
31. Harvey RJ, Wallwork BD, Lund VJ. Anti-inflammatory effects of macrolides: applications in chronic rhinosinusitis. Immunol Allergy Clin North Am 2009; 29: 689–703.
 
32. Solares CA, Batra PS, Hall GS, et al. Treatment of chronic rhinosinusitis exacerbations due to methicillin-resistant Staphylococcus aureus with mupirocin irrigations. Am J Otolaryngol 2006; 27: 161–165.
 
33. Ha KR, Psaltis AJ, Butcher AR, et al. In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis. Laryngoscope 2008; 118: 535–540.
 
34. Uren B, Psaltis A, Wormald PJ. Nasal lavage with mupirocin for the treatment of surgically recalcitrant chronic rhinosinusitis. Laryngoscope 2008; 118: 1677–1680.
 
35. American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics 2004; 113: 1451–1465.
 
36. World Health Organization. Chronic suppurative otitis media. Burden of illness and management options. 2004. Available at: http://www.who.int/pbd/deafness/activities/hearing_care/otitis_media.pdf. Accessed June 2011.
 
37. Kaji C, Watanabe K, Apicella M, et al. Antimicrobial effect of fluoroquinolones for the eradication of nontypeable Haemophilus influenzae isolates within biofilm. Tohoku J Exp Med 2008; 214: 121–128.
 
38. Leibovitz E, Greenberg D, Piglansky L, et al. Recurrent acute otitis media occurring within one month from completion of antibiotic therapy: relationship to the original pathogen. Pediatr Infect Dis J 2003; 22: 209–216.
 
39. Dagan R, Leibovitz E, Cheletz G, et al. Antibiotic treatment in acute Otitis Media promotes superinfection with resistant Streptococcus pneumoniae carried before initiation of treatment. J Infect Dis 2001; 183: 880–886.
 
40. Gates GA, Avery CA, Prohoda TJ, et al. Effectiveness of adenoidectomy and tympanostomy tubes in the treatment of chronic otitis media with effusion. N Engl J Med 1987; 317: 1444–1451.
 
41. Tenke P, Kovacs B, Bjerklund Johansen TE, et al. European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. Int J Antimicrob Agents 2008; 31 (1 suppl): S68–S78.
 
42. Wilson M, Wilde M, Webb ML, et al. Nursing interventions to reduce the risk of catheter-associated urinary tract infection: part 2: staff education, monitoring, and care techniques. J Wound Ostomy Continence Nurs 2009; 36: 137–154.
 
43. Falagas ME, Kapaskelis AM, Kouranos VD, et al. Outcome of antimicrobial therapy in documented biofilm-associated infections: a review of the available clinical evidence. Drugs 2009; 69: 1351–1361.
 
44. Drekonja DM, Kuskowski MA, Johnson JR. Internet survey of Foley catheter practices and knowledge among Minnesota nurses. Am J Infect Control 2010; 38: 31–37.
 
45. Drekonja DM, Kuskowski MA, Johnson JR. Foley catheter practices and knowledge among Minnesota physicians. Am J Infect Control 38: 694–700.
 
46. Fakih MG, Dueweke C, Meisner S, et al. Effect of nurse-led multidisciplinary rounds on reducing the unnecessary use of urinary catheters in hospitalized patients. Infect Control Hosp Epidemiol 2008; 29: 15–19.
 
47. Topal J, Conklin S, Camp K, et al. Prevention of nosocomial catheter-associated urinary tract infections through computerized feedback to physicians and a nurse-directed protocol. Am J Med Qual 2005; 20: 121–126.
 
48. Parker D, Callan L, Harwood J, et al. Nursing interventions to reduce the risk of catheter-associated urinary tract infection. Part 1: catheter selection. J Wound Ostomy Continence Nurs 2009; 36: 23–34.
 
49. Stickler DJ, Morgan SD. Observations on the development of the crystalline bacterial biofilms that encrust and block Foley catheters. J Hosp Infect 2008; 69: 350–360.
 
50. Morgan SD, Rigby D, Stickler DJ. A study of the structure of the crystalline bacterial biofilms that can encrust and block silver Foley catheters. Urol Res 2009; 37: 89–93.
 
51. Moore KN, Hunter KF, McGinnis R, et al. Do catheter washouts extend patency time in long-term indwelling urethral catheters? A randomized controlled trial of acidic washout solution, normal saline washout, or standard care. J Wound Ostomy Continence Nurs 2009; 36: 82–90.
 
52. Percival SL, Sabbuba NA, Kite P, et al. The effect of EDTA instillation on the rate of development of encrustation and biofilms in Foley catheters. Urol Res 2009; 37: 205–209.
 
53. Fisher TK, Wolcott R, Wolk DM, et al. Diabetic foot infections: a need for innovative assessments. Int J Low Extrem Wounds 2010; 9: 31–36.
 
54. Percival SL, Bowler P, Woods EJ. Assessing the effect of an antimicrobial wound dressing on biofilms. Wound Repair Regen 2008; 16: 52–57.
 
55. Wolcott RD, Rhoads DD. A study of biofilm-based wound management in subjects with critical limb ischaemia. J Wound Care 2008; 17: 145–155.
 
56. Wolcott RD, Rhoads DD, Bennett ME, et al. Chronic wounds and the medical biofilm paradigm. J Wound Care 2010; 19: 45–46, 48–50, 52–53.
 
57. Edwards J, Stapley S. Debridement of diabetic foot ulcers. Cochrane Database Syst Rev 2010: CD003556.
 
58. Fleck CA. Wound infection and modern biocides. US Dermatol Rev 2006:1–4. Available at emerginghcs.com/.../Wound%20Infection%20and%20Modern%20Biocides.pdf. Accessed June 2011.
 
59. Rosenthal D, Murphy F, Gottschalk R, et al. Using a topical anaesthetic cream to reduce pain during sharp debridement of chronic leg ulcers. J Wound Care 2001; 10: 503–505.
 
60. Margolis DJ, Kantor J, Santanna J, et al. Risk factors for delayed healing of neuropathic diabetic foot ulcers: a pooled analysis. Arch Dermatol 2000; 136: 1531–1535.
 
61. Tan JS. Diagnosis and management of diabetic foot infection. Adv Stud Med 2006; 6: S549–S554.
 
62. Bader MS. Diabetic foot infection. Am Fam Physician 2008; 78: 71–79.
 
63. Lipsky BA, Berendt AR, Deery HG, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004; 39: 885–910.
 
64. Rao N, Lipsky BA. Optimising antimicrobial therapy in diabetic foot infections. Drugs 2007; 67: 195–214.
 
65. Valabhji J, Oliver N, Samarasinghe D, et al. Conservative management of diabetic forefoot ulceration complicated by underlying osteomyelitis: the benefits of magnetic resonance imaging. Diabetes Med 2009; 26: 1127–1134.
 
66. Lipsky BA, Holroyd KJ, Zasloff M. Topical versus systematic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream. Clin Infect Dis 2008; 47: 1537–1545.
 
67. Letendre S, LaPorta G, O’Donnell E, et al. Pilot trial of biovance collagen-based wound covering for diabetic ulcers. Adv Skin Wound Care 2009; 22: 1–6.